Diosmetin attenuates fibromyalgia-like symptoms in a reserpine-induced model in mice
Inflammopharmacology · 2024-08 · 32 (4) · 2601-2611
DOI: 10.1007/s10787-024-01473-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Inflammopharmacology, online erschienen am 25.04.2024. Verfasst von Lara Panazzolo Marquezin und 6 weiteren Autor:innen. Beteiligte Einrichtung: Neurotoxicity and Psychopharmacology Laboratory-Pain Research Group, Centre of Natural and Exact Sciences, Federal University of Santa Maria, Santa M…. Hauptthemen laut MEDLINE: Reserpine, Fibromyalgia, Disease Models, Animal, Flavonoids. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 59 Literaturangaben. Gefördert von: Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul, Conselho Nacional de Desenvolvimento Científico e Tecnológico.
Abstract (Originalsprache)
Fibromyalgia is a potentially disabling idiopathic disease characterized by widespread chronic pain associated with comorbidities such as fatigue, anxiety, and depression. Current therapeutic approaches present adverse effects that limit adherence to therapy. Diosmetin, an aglycone of the flavonoid glycoside diosmin found in citrus fruits and the leaves of Olea europaea L., has antinociceptive, anti-inflammatory, and antioxidant properties. Here, we investigated the effect of diosmetin on nociceptive behaviors and comorbidities in an experimental fibromyalgia model induced by reserpine in mice. To induce the experimental fibromyalgia model, a protocol of subcutaneous injections of reserpine (1 mg/kg) was used once a day for three consecutive days in adult male Swiss mice. Mice received oral diosmetin on the fourth day after the first reserpine injection. Nociceptive (mechanical allodynia, muscle strength, and thermal hyperalgesia) and comorbid (depressive-like and anxiety behavior) parameters were evaluated. Potential adverse effects associated with diosmetin plus reserpine (locomotor alteration, cataleptic behavior, and body weight and temperature changes) were also evaluated. Oral diosmetin (0.015-1.5 mg/kg) reduced the mechanical allodynia, thermal hyperalgesia, and loss of muscle strength induced by reserpine. Diosmetin (0.15 mg/kg) also attenuated depressive-like and anxiety behaviors without causing locomotor alteration, cataleptic behavior, and alteration in weight and body temperature of mice. Overall, diosmetin can be an effective and safe therapeutic alternative to treat fibromyalgia symptoms, such as pain, depression and anxiety.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Neurotoxicity and Psychopharmacology Laboratory-Pain Research Group, Centre of Natural and Exact Sciences, Federal University of Santa Maria, Santa Maria, RS, Brazil.
- Graduate Program in Biological Sciences: Toxicological Biochemistry, Centre of Natural and Exact Sciences, Federal University of Santa Maria, Santa Maria, RS, Brazil.
- Department of Microbiology and Parasitology, Federal University of Santa Maria, Santa Maria, RS, Brazil.
- Department of Biochemistry and Molecular Biology, Centre of Natural and Exact Sciences, Federal University of Santa Maria, Santa Maria, RS, Camobi, 97105-900, Brazil.
- Neurotoxicity and Psychopharmacology Laboratory-Pain Research Group, Centre of Natural and Exact Sciences, Federal University of Santa Maria, Santa Maria, RS, Brazil. saramarchesan@ufsm.br.
- Graduate Program in Biological Sciences: Toxicological Biochemistry, Centre of Natural and Exact Sciences, Federal University of Santa Maria, Santa Maria, RS, Brazil. saramarchesan@ufsm.br.
Förderung
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
Zitieren
APA
Marquezin, L. P., Fialho, M. F. P., Favarin, A., de Lara, J. D., Pillat, M. M., Rosemberg, D. B., & Oliveira, S. M. (2024). Diosmetin attenuates fibromyalgia-like symptoms in a reserpine-induced model in mice. Inflammopharmacology, 32(4), 2601-2611. https://doi.org/10.1007/s10787-024-01473-4
Vancouver
Marquezin LP, Fialho MFP, Favarin A, de Lara JD, Pillat MM, Rosemberg DB, et al. Diosmetin attenuates fibromyalgia-like symptoms in a reserpine-induced model in mice. Inflammopharmacology. 2024;32(4):2601-2611. doi:10.1007/s10787-024-01473-4
BibTeX
@article{Marquezin2024,
author = {Marquezin, Lara Panazzolo and Fialho, Maria Fernanda Pessano and Favarin, Amanda and de Lara, Jéssica Dotto and Pillat, Micheli Mainardi and Rosemberg, Denis Broock and Oliveira, Sara Marchesan},
title = {Diosmetin attenuates fibromyalgia-like symptoms in a reserpine-induced model in mice},
journal = {Inflammopharmacology},
year = {2024},
volume = {32},
number = {4},
pages = {2601--2611},
doi = {10.1007/s10787-024-01473-4}
}
EUVIMED